Skip to main content
Equibles

Pallas Capital Advisors LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1862282 BRAINTREE, MA
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,092,806
+$361,374 QoQ
Shares Held
2,200
+34.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#821
of 1,745 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 67% Shared 0% None 33%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Pallas Capital Advisors LLC holds $30,351,010 across 36 Biotechnology names. VRTX ranks #6 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
 40,511 $9,915,877
2 RPRX
Royalty Pharma plc
 108,585 $6,088,360
3 INCY
Incyte Corp
 32,151 $3,644,637
4 EXEL
Exelixis, Inc.
 30,721 $1,671,529
5 REGN
Regeneron Pharmaceuticals, Inc.
 1,920 $1,197,196
6 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		2,200 $1,092,806
7 FTRE
Fortrea Holdings Inc.
 39,499 $687,282
8 ALNY
Alnylam Pharmaceuticals, Inc.
 2,203 $663,169

All Filings in VRTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,092,806 2,200
2026-03-31 $731,432 1,638
2025-12-31 $1,922,699 4,241
2025-09-30 $1,131,056 2,888
2025-06-30 $1,361,866 3,059
2025-03-31 $1,202,353 2,480
2024-12-31 $991,044 2,461
2024-09-30 $1,109,680 2,386
2024-06-30 $1,120,709 2,391
2024-03-31 $300,131 718
2023-12-31 $240,065 590
2023-09-30 $226,378 651
2023-06-30 $224,166 637
2021-09-30 $226,193 1,247
2021-06-30 $2,026,381 10,050
2021-03-31 $1,803,571 8,393